Lung carcinoma
MONDO:0005138A carcinoma that arises from epithelial cells of the lung
Also known as: cancer of lung, cancer of the lung, lung cancer, lung cancer, NOS, carcinoma of lung, carcinoma of the lung, lung carcinoma
5821 clinical trials for this condition and its sub-types, 137 tagged with Lung carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lung carcinoma
-
Non-small cell lung carcinoma 2,721 trials · 2,834 incl. sub-types
3 sub-types
- Lung adenocarcinoma 114 trials · 117 incl. sub-types Sub-types →
- Non-small cell squamous lung carcinoma 83 trials · 88 incl. sub-types Sub-types →
- Lung large cell carcinoma 11 trials · 37 incl. sub-types Sub-types →
-
Small cell lung carcinoma 514 trials · 515 incl. sub-types
2 sub-types
-
Squamous cell lung carcinoma 65 trials · 145 incl. sub-types
2 sub-types
- Non-small cell squamous lung carcinoma 83 trials · 88 incl. sub-types Sub-types →
- Lung occult squamous cell carcinoma 0 trials
-
Bronchogenic carcinoma 25 trials
2 sub-types
- Bronchus carcinoma in situ 0 trials
- Bronchus mucoepidermoid carcinoma 0 trials
-
Lung carcinoma in situ 2 trials · 3 incl. sub-types
2 sub-types
- Lung adenocarcinoma in situ 1 trial
- Bronchus carcinoma in situ 0 trials
-
Combined lung carcinoma 0 trials · 1 incl. sub-types
2 sub-types
-
Asbestos-related lung carcinoma 0 trials
-
Lung hilum carcinoma 0 trials
Most studied deeper sub-types
-
New drug cocktail shows promise in tough lung cancers
Disease control Stopped earlyThis study tested a new drug called TQB3616 combined with either anlotinib or standard chemotherapy in 21 people with advanced lung cancer that had already been treated. The goal was to see if the combination could shrink tumors or slow the cancer's growth. The study was stopped …
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Promising cancer combo trial halted early
Disease control Stopped earlyThis study tested a new drug (BMS-986218) plus nivolumab and targeted radiation in people with advanced solid tumors that had spread. The goal was to see if this combination could help the immune system fight cancer better. Only 13 people took part before the study was stopped ea…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heat therapy for lung cancer: early trial ends early
Disease control Stopped earlyThis study looked at using a microwave ablation device to destroy lung tumors in people who could not have surgery or chose not to. It included 13 adults with non-small cell lung cancer or tumors that had spread to the lung. The treatment was given through a needle inserted into …
Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New laser imaging aims to spot lung cancer in real time
Diagnosis Stopped earlyThis study tested whether adding a special laser imaging technique (nCLE) and a dye (fluorescein) to a standard needle biopsy could help doctors diagnose lung cancer more accurately. The plan was to compare the combined approach to the standard biopsy alone in people with suspici…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 26, 2026 18:31 UTC
-
Blood test may spot lung cancer without a needle biopsy
Diagnosis Stopped earlyThis study looked at whether a blood test (called a fluid biopsy) could help diagnose lung cancer. Researchers collected blood samples from 51 people who were either scheduled for a lung biopsy or had recently had one. The goal was to see if the blood test could accurately detect…
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 26, 2026 13:46 UTC
-
Lung cancer video trial fails to reach goal
Knowledge-focused Stopped earlyThis study aimed to see if a culturally tailored educational video could help African American, Korean, and Chinese adults learn about lung cancer and screening. Researchers planned focus groups and interviews with 11 participants to understand barriers. The trial was terminated …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Lung cancer biomarker study halted after enrolling only 22 patients
Knowledge-focused Stopped earlyThis study aimed to find genetic changes in lung tissue and blood that could predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 patients undergoing lung procedures, but the study was stopped early with only 22 participants. No treatm…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC